Home > Insider Trading > Filing (0000899243-22-024429)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1891241	Ali Kiboro	C/O Quotient Limited, Business Park Terre Bonne, Route De Crassier 13 Eysins V8 1262	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-06-24	66,666	$0.30	66,666	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Restricted Stock Units	$0.00			122,095	122,095	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$2.08		2031-11-19	123,267	123,267	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	122,095	122,095	Direct
2031-11-19	123,267	123,267	Direct

Footnotes

Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On November 19, 2021, the Reporting Person was granted 122,095 Restricted Stock Units. The Restricted Stock Units will vest in three years, with 50% vesting on November 19, 2022 and 25% vesting on each of the second and third anniversaries of the initial vesting date. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).
The option vests and becomes exercisable in three equal annual installments beginning on November 19, 2022. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).